The same pills that appeared to increase risk in the healthy seemed to offer protection in the already-vulnerable.
Por décadas, o óleo de peixe ocupou um lugar quase inquestionável nas prateleiras das farmácias e nas rotinas matinais de milhões de pessoas, carregando a promessa silenciosa de um coração mais saudável. Um estudo britânico publicado no BMJ Medicine, acompanhando mais de 415 mil pessoas por cerca de doze anos, veio perturbar essa certeza: para quem não tem histórico de doenças cardiovasculares, o uso regular do suplemento está associado a um risco 13% maior de fibrilação atrial e 5% maior de acidente vascular cerebral. A ciência, mais uma vez, lembra que aquilo que protege um pode prejudicar outro — e que a fronteira entre prevenção e tratamento raramente é simples.
- Um suplemento consumido por milhões de brasileiros como escudo preventivo pode, paradoxalmente, aumentar o risco de AVC e arritmia em pessoas saudáveis.
- O estudo rastreou mais de 415 mil pessoas por doze anos e revelou que cerca de um terço usava óleo de peixe regularmente — sem saber dos riscos potenciais associados ao seu perfil de saúde.
- A mesma substância que eleva riscos em pessoas sem doença cardíaca reduz em 15% a progressão para infarto e em 9% a mortalidade pós-insuficiência cardíaca em quem já tem o coração comprometido.
- Os pesquisadores reconhecem lacunas importantes: ausência de dados sobre dosagem, formulações específicas e diversidade étnica limitam a aplicação universal dos resultados.
- A orientação médica personalizada emerge como resposta necessária — o suplemento não é uma solução universal, e a decisão de tomá-lo ou abandoná-lo exige avaliação individual.
Uma equipe britânica publicou no BMJ Medicine resultados que desafiam uma das convicções mais enraizadas na cultura de saúde contemporânea: a de que óleo de peixe é um aliado incondicional do coração. Após acompanhar mais de 415 mil pessoas entre 40 e 69 anos por cerca de doze anos, os pesquisadores identificaram que, entre aquelas sem histórico de doenças cardiovasculares, o uso regular do suplemento estava associado a um risco 13% maior de fibrilação atrial e 5% maior de AVC. Aproximadamente um terço dos participantes relatou consumir óleo de peixe com regularidade.
O paradoxo central do estudo está no que os dados revelaram sobre quem já tinha doenças cardíacas. Para esse grupo, o cenário se inverteu: o suplemento foi associado a uma redução de 15% no risco de progressão para infarto e a uma queda de 9% na mortalidade após insuficiência cardíaca. O mesmo comprimido que parece aumentar riscos em pessoas saudáveis demonstrou efeito protetor naquelas já vulneráveis.
Os próprios autores reconheceram limitações relevantes: a ausência de informações sobre dosagem e formulações específicas, além de uma população de estudo predominantemente branca, restringem a generalização dos achados. Esses fatores importam porque a composição e a quantidade do suplemento podem alterar significativamente seus efeitos no organismo.
A conclusão prática é clara: óleo de peixe não é uma intervenção universal. Quem o consome como medida preventiva sem ter doença cardíaca pode precisar reavaliar essa escolha. Quem já tem o coração comprometido pode estar tomando uma decisão acertada ao mantê-lo. O estudo reforça uma distinção que cardiologistas conhecem bem, mas que frequentemente se perde na comunicação popular — prevenção e tratamento obedecem a lógicas distintas, e o que beneficia um paciente pode prejudicar outro. Antes de iniciar ou continuar qualquer suplementação, a conversa com um médico deixa de ser recomendável para se tornar indispensável.
A British research team publishing in BMJ Medicine has upended a common assumption about fish oil supplements—the kind millions of Brazilians take each morning believing they're protecting their hearts. The study followed more than 415,000 people aged 40 to 69 for roughly a dozen years and found something counterintuitive: among those without any prior history of heart disease, regular fish oil use was tied to a 13 percent higher risk of atrial fibrillation, a type of irregular heartbeat, and a 5 percent increased risk of stroke. About one-third of the study participants reported taking fish oil supplements regularly.
The findings complicate a narrative that has dominated health conversations for decades. Fish oil is rich in omega-3 fatty acids, nutrients long celebrated for supporting brain function and cardiovascular health. The scientific literature on the subject, however, has always been messier than the marketing suggests. This new research adds weight to the growing evidence that the relationship between fish oil and heart health depends heavily on who is taking it.
The paradox lies in what the data revealed about people who already had cardiovascular disease. For them, fish oil told a different story entirely. Those with existing heart conditions who took the supplement saw their risk of progressing to a heart attack drop by 15 percent. The supplement was also associated with a 9 percent reduction in mortality following heart failure. The same pills that appeared to increase risk in the healthy seemed to offer protection in the already-vulnerable.
The researchers themselves flagged important gaps in their work. They had no detailed information about how much fish oil people were actually taking, or what specific formulations they used. The study population skewed heavily toward white participants, which means the findings may not apply equally across different ethnic groups. These limitations matter because dosage and composition can shift how a supplement behaves in the body. The authors emphasized that more targeted research is needed to understand which people benefit from fish oil and which should avoid it.
The practical implication is straightforward: fish oil is not a one-size-fits-all intervention. Someone without heart disease who has been taking fish oil supplements as preventive medicine may need to reconsider that choice. Someone whose heart is already damaged may be making a wise decision by continuing. The study underscores what cardiologists have long known but patients often overlook—that prevention and treatment are not the same thing, and what helps one person can harm another.
The research also served as a reminder about stroke recognition. The warning signs—sudden weakness on one side of the body, difficulty speaking, severe headaches with no apparent cause—require immediate medical attention. Early diagnosis dramatically improves recovery odds. Beyond supplements, the modifiable risk factors remain familiar: high blood pressure, elevated cholesterol, diabetes, physical inactivity, smoking, obesity, and heavy alcohol use all increase cardiovascular risk and deserve attention regardless of what supplements someone is taking.
Brazil's health ministry has reinforced the importance of seeking emergency care at the first sign of stroke symptoms. The broader message from this research is that before adding any supplement to a daily routine, a conversation with a doctor is not optional—it is essential. Fish oil may be widely used, but its effects vary significantly depending on individual health status, and personalized medical guidance should precede any decision to start or continue taking it.
Notable Quotes
The study's authors emphasized that more targeted research is needed to understand which people benefit from fish oil and which should avoid it, citing lack of detailed dosage information and demographic limitations.— BMJ Medicine study researchers
Brazil's health ministry reinforced the importance of seeking emergency care at the first sign of stroke symptoms, noting that early diagnosis dramatically improves recovery odds.— Brazilian Ministry of Health
The Hearth Conversation Another angle on the story
So the study found that fish oil increases stroke risk in healthy people. But it helps people who already have heart disease. How do we explain that contradiction?
It's not actually a contradiction—it's about what the supplement does to the heart's electrical system. In someone without disease, fish oil can trigger arrhythmias, irregular rhythms that can lead to clots and strokes. But in someone whose heart is already compromised, those same properties seem to stabilize the tissue and prevent further damage.
That's interesting. So the supplement's effect depends on the baseline condition of the person taking it?
Exactly. It's like adding a medication to a system that's already broken versus a system that's working fine. The broken system sometimes benefits from the intervention. The working system can be disrupted by it.
The study tracked over 415,000 people for 12 years. That's a massive dataset. Why are the researchers still calling for more research?
Because they don't know the dosages people were actually taking, or which brands or formulations they used. Someone taking 500 milligrams a day has a different exposure than someone taking 3,000. And the study was mostly white participants, so we don't know if the findings hold across different populations.
So a Brazilian taking fish oil right now should do what?
Talk to their doctor. If they have no heart disease history, the risk-benefit calculation has shifted. If they do have heart disease, the supplement may still be worth taking. But that decision needs to be made with medical guidance, not just habit or marketing.